STL Genome Editing 2021…Virtually A New Beginning

Did you miss the talks?

Check out the recordings below.

To review the posters, visit here.


Day 1  January 21, 2021, 8 AM to 1 PM

  • Charlie Gersbach, Ph.D., Rooney Family Associate Professor of Biomedical Engineering, Duke University
    • Decoding and Programming the Genome with CRISPR Technologies
  • Ibrahim Kurt, Ph. D.  Candidate, Harvard University
    • CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells
  • Traver Hart, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center
    • CRISPR screening for functional genomics and cancer targeting
  • Shengdar Tsai, Assistant Member of the Department of Hematology, St. Jude Children’s Research Hospital
    • Understanding genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity with CHANGE-seq
  • Tim Peterson, Assistant Professor of Medicine, Washington University in St. Louis
    • “Sphingolipids connect pathogens to aging-related disease”
  • John Doench, Director R&D, Institute Scientist, Broad Institute of MIT and Harvard University
    • “Massively parallel variant-to-function mapping with CRISPR base editor screens”
  • Andrew Anzalone, Head of the Prime Editing Platform at Prime Medicine, Inc.
    • “Prime Editing: Versatile and Precise Genome Editing without Double-strand Breaks or Donor DNA”
  • Panel Discussion:
    • Including Monica Sentmanat, Ph.D./Assistant Director of GEiC, Steven Hoffman Illumina, Cell & Molecular Biology Segment Manager, and other speakers from the event
    • “Off targeting using nucleases, base editors, prime editors, and in screens”

Day 2.  January 22, 2021, 8 AM to 1 PM

  • 8 AM Alejandro Chavez,  Assistant Professor of Pathology & Cell Biology, Columbia University
    • “Controlling gene expression with CRISPR-based tools”
  • 8:30 AM Dongsheng Duan, Margaret Proctor Mulligan Professor in Medical Research, School of Medicine, University of Missouri, Columbia
    • “CRISPR editing therapy for Duchenne muscular dystrophy”
  • 9 AM Aron Geurts, Associate Professor, Department of Physiology,  Medical College of Wisconsin
    • Engineering Rats and Rat Model Resources
  • 9:30 AM Xiaoxia Cui, Director of the Genome Engineering & iPSC Center, Washington University in St. Louis
    • Reliable and Efficient Creation of Floxed Alleles in Mice
  • 10 AM Andrew Yoo, Associate Professor of Developmental Biology,  Washington University in St. Louis
    • “Modeling late-onset neurodegenerative disorders via direct neuronal reprogramming of patient fibroblasts”
  • 10:30 AM Martin Kampmann, Associate Professor, Institute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California, San Francisco
    • “CRISPR-based functional genomics in iPSC-derived models of brain disease”
  • 11 AM. Luke Gilbert, Assistant Professor, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
    • “Genome-wide Programmable Transcriptional Memory by CRISPR-based Epigenome Editing”
  • 11:30 AM Michael Kosicki, Postdoctoral Fellow, Lawrence Berkeley National Laboratory
    • “Large deletions, small trouble”
  • 12 PM Panel Discussion:
    • Including Yi-Hsien Chen, Ph.D./Assistant Director of GEiC, Steven Hoffman Illumina, Cell & Molecular Biology Segment Manager, and other speakers from the event
    • “On target large deletion, repression as KO alternative, off-targeting potential, continue first days”